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Abstract. It has been suggested, on the basis of immu- 
nolocalization studies in vivo and antibody blocking ex- 
periments in vitro, that a n integrins interacting with vas- 
cular cell adhesion molecule 1 (VCAM-1) are involved 
in myogenesis and skeletal muscle development. To 
test this proposal, we generated embryonic stem (ES) 
cells homozygous null for the gene encoding the a 4 sub- 
unit and used them to generate chimeric mice. These 
chimeric mice showed high contributions of an-null 
cells in many tissues, including skeletal muscle, and 
muscles lacking any detectable (<2%) an-positive cells 
did not reveal any gross morphological abnormalities. 
Furthermore, assays for in vitro myogenesis using ei- 
ther pure cultures of an-null myoblasts derived from the 
chimeras or an-null ES cells showed conclusively  that a  n 
integrins are not essential for muscle cell fusion and dif- 
ferentiation. Taking these results together, we conclude 
that ot  n integrins appear not to play essential roles in 
normal skeletal muscle development. 
EVELOPMENT of skeletal muscle is a multistep pro- 
cess. During embryogenesis, myogenic precursor 
cells in the somites form myoblasts that prolifer- 
ate, migrate, and eventually exit the cell cycle and differ- 
entiate into postmitotic multinucleated myotubes. The for- 
mation of mature muscle involves a biphasic fusion process. 
Primary myoblasts first fuse with one another to form pri- 
mary myotubes; secondary myoblasts then proliferate and 
progressively fuse to form secondary myotubes juxtaposed 
to the primary myotubes. Eventually, the myotubes, most 
of which are secondary myotubes, specialize  as fast and 
slow  contracting fibers  and become  striated and  inner- 
vated (Kelly and Rubenstein, 1994). 
In each stage of skeletal muscle development, cell-cell 
and cell-extracellular matrix adhesion are thought to play 
critical roles.  Inhibition of in vitro myogenic differentia- 
tion by antibodies has been interpreted to suggest that ad- 
hesion molecules such as NCAM (Knudsen et al., 1990a) 
and N-cadherin (Knudsen et al., 1990b) are involved. Sim- 
ilarly, myogenic differentiation can be inhibited in culture 
with antibodies against o~4 integrins or their counterrecep- 
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tor vascular cell adhesion molecule 1 (VCAM-1) 1 (Rosen 
et al. 1992). These adhesion receptors have also been im- 
plicated in secondary myotube formation based on their 
patterns of expression  during development (Rosen et al., 
1992; Sheppard et al., 1994). Finally, studies of expression 
patterns have also implicated et7131 integrin (Song  et al., 
1993) and M-cadherin (Cifuentes-Diaz et al., 1995) in sec- 
ondary myogenesis. 
Integrins are a13  heterodimeric transmembrane glyco- 
proteins that mediate cell adhesion to extracellular matrix 
by interacting with a number of extracellular matrix pro- 
teins such as fibronectin, laminin, collagen, and vitronec- 
tin. Integrins also mediate cell-cell adhesion by interacting 
with members of the immunoglobulin superfamily (Hynes, 
1992). The integrin family so far has >20 known members, 
assembled from various combinations of 16 et subunits and 
8 13 subunits. Among these integrins, those containing the 
et4 subunit have been implicated in skeletal muscle devel- 
opment and in other developmental and physiological pro- 
cesses  such  as hematopoiesis (Williams  et al.,  1991; Mi- 
yake  et  al.,  1991; Papayannopoulou  and  Brice,  1992; 
Hemler, 1990; Arroyo et al.,  1996), lymphocyte homing 
(Holzmann et al., 1989; Berlin et al., 1993), recruitment of 
inflammatory cells (Yednock et al., 1992), and metastasis 
(Qian et al., 1994). The integrin ~4 subunit can be assem- 
1.  Abbreviations  used  in  this paper:  ES, embryonic stem; GPI, glucose 
phosphate isomerase; LIF, leukemia inhibitory factor; VCAM-1, vascular 
cell adhesion molecule 1. 
© The Rockefeller University Press, 0021-9525/96/11/829/7  $2.00 
The Journal of Cell Biology, Volume 135, Number 3, November 1996 829-835  829 bled into two integrin heterodimers, et4[~l and et4~7" Both 
et4131 and et4[~7  are fibronectin receptors that bind to a non- 
RGD peptide in an alternatively spliced V25 (or CS-1) re- 
gion (Guan and Hynes, 1990; Mould et al., 1990; Ruegg et 
al.,  1992).  Both et4131 and et4137 also bind to VCAM-1,  a 
member of the immunoglobulin superfamily (Chan et al., 
1992). 
To study the in vivo functions of et4 integrins further, we 
have previously generated a null mutation in the gene en- 
coding the ot  4 subunit and shown that the mutation is re- 
cessive embryonic lethal. The resulting embryonic defects 
show that  ot  4 integrins  have  important  functions in  two 
cell-cell adhesion events during embryogenesis: allantois- 
chorion fusion during placental development, and epicar- 
dium-myocardium  attachment  during  cardiac  develop- 
ment (Yang et al., 1995). However, it was not possible to 
address the question of whether a 4 integrins play an essen- 
tial role in skeletal muscle development, since the embryos 
deficient in et4 integrins died at gestation days 11-13, whereas 
skeletal muscles form around gestation day 13. 
To examine the role of et4 integrins in muscle develop- 
ment, in this study we generated chimeric mice using ot  4 in- 
tegrin-deficient embryonic stem (ES) cells to circumvent 
the problem of embryonic lethality. We report that et  a inte- 
grin--deficient ES cells are able to contribute to adult skel- 
etal muscle in high proportion. Skeletal  muscle derived 
primarily, if not exclusively, from et4 integrin--deficient ES 
cells displays no obvious morphological abnormalities. In 
addition, we show that myoblasts and ES cells completely 
•  lacking ot  4 integrins are both fully competent to differenti- 
ate into myotubes in vitro. These results suggest that, in 
contrast with the implication of previous reports, ot  4 inte- 
grins are not essential for skeletal muscle differentiation 
during development. 
Materials and Methods 
Growth, Selection, and Differentiation of ES Cells 
Mutant in the c~  4 Integrin Gene 
The methods for growth of ES cells were described previously (George 
et al.,  1993; George and Hynes, 1994).  The D3 line of ES cells (Doet- 
schman  et  al.,  1985)  was  cultured  on  irradiated  embryonic fibroblast 
feeder cells in ES cell medium, which contains DME (high glucose with 
26 mM Hepes, pH 7.5, 14 mM sodium bicarbonate), 15% FBS (Intergen 
Co. Purchase, NY), 1 × nonessential amino acids (GIBCO BRL, Gaithers- 
burg, MD), and 0.1 mM 13-mercaptoethanol,  supplemented with 1,000 U/mi 
leukemia inhibitory factor (LIF) (ESGRO; GIBCO BRL). 
A  heterozygous a4 integrin knockout ES cell line, 182  (Yang et al., 
1995),  was  expanded  and  selected with  1  mg/ml  or  1.5  mg/ml  G418 
(GIBCO BRL). After 7-9 d of selection, the drug-resistant colonies were 
picked and expanded on feeder cells. Half of the ceils from each colony 
were frozen in 10% DMSO in FBS and half were lysed for extraction and 
analysis of DNA. 
For differentiation, ES cells were trypsinized and resuspended in ES 
medium without LIF. The cell suspension was plated and incubated under 
standard tissue-culture conditions (the same for all the incubations below) 
for 30 rain to remove the feeder cells. Unattached ES cells were removed 
from the plate, spun down, and resuspended in LIF-free ES medium at 1 
×  104 cells per ml. 10-1xl drops, each containing ~100 ES cells, were put 
onto a cover of a large bacterial petri dish. The cover was placed onto a 
petri dish containing medium to maintain humidity, and the petri dish 
with the hanging drop ES cultures was incubated at 37°C. After 2 d the 
hanging drops of ES cells were washed into LIF-free ES medium in the 
petri dish and incubated for an additional 2 d. Embryoid bodies formed 
from the ES cells and were plated into 24-well plates. Each well contained 
1 ml LIF-free ES medium and a coverslip coated with 0.1% gelatin (type 
II swine gelatin; Sigma Chemical Co., St. Louis, MO). Two embryoid bod- 
ies were plated in each well. The embryoid bodies were incubated for 30 d 
with daily feeding with LIF-free ES medium. The differentiated ES cells 
were fixed in methanol for 5 min, and immunobistochemical staining was 
performed with an antibody against skeletal muscle myosin heavy chain 
(MY32; Sigma Chemical Co.), using the Veetastain Elite ABC kit from 
Vector Laboratories, Inc. (Burlingame, CA). 
For generating chimeric mice, ES cells were prepared and injected into 
C57BL/6J blastocysts as described by George et al.  (1993)  and George 
and Hynes (1994).  Blastocysts were manipulated as described (Bradley, 
1987). Chimeric progeny were identified by coat color. The effficiencies of 
generation of chimeras from eq-null, a4-heterozygous, and wild-type ES 
cells were all equivalent. 
DNA Extraction, Southern Blot, and PCR Analyses 
ES cells or myoblast cells were washed with PBS (140 mM NaCI, 3 mM 
KC1, 4 mM Na2HPO4,1.5 mM KH2PO4, pH 7.2) and lysed with lysis buffer 
(150 mM NaC1, 20 mM "Iris, pH 7.5, 5 rnM EDTA. 0.5% SDS, and 0.25 mg/ml 
proteinase K) for 30 min at 37°C. The lysates were stored at -20°C. DNA 
was prepared from the lysates by phenol extraction and ethanol precipita- 
tion, and redissolved in 50/~1 of 10 mM Tris (pH 7.5) and 0.1 mM EDTA. 
Southern blot analyses were carded out as described elsewhere (Church 
and Gilbert, 1984), using a 1.4-kb  KpnI/PstI fragment 5' of the targeting 
vector as a probe for genotyping the ES cells (Yang et al., 1995). 
PCR reaction conditions were essentially those described by the manu- 
facturer of Taq polymerase (Perkin-Elmer Cetus Corp., Norwalk, CT), 
except that primers were annealed for 2 rain at 55°C in each cycle and 40 
amplification cycles were  performed. The  oligonucleotide primers for 
PCR  were  as follows: et  4 integrin wild-type primers are  5'-CACTAC- 
GATCGTCCGCTGTG-3'  and  5'-GAAGTACAACAACAGCATCA- 
CCG-3';  Neo  primers  (for  control)  are  (5'-GACAATCGGCTGCT- 
CTGA-3' and 5'-GCAGGCATCGCCATG-3'. The amplified PCR products 
were separated by electrophoresis on 1% agarose gels and analyzed by 
Southern blot hybridization (Church and Gilbert, 1984) using a probe for 
the a4 integrin wild-type allele (a 950-bp Pstl/BsmI fragment; see Yang et 
al., 1995). For controls, the blot was rehybridized with a 650-bp PstI/BamHI 
fragment containing the coding sequence of the neomycin gene (Yenofsky 
et al., 1990). 
Glucose Phosphate Isomerase Analysis of Muscle 
Glucose phosphate isomerase (GPI) analysis was performed on extracts 
of whole muscle and on extracts from muscle cryosections. For whole 
muscle analysis, muscles were dissected, frozen in liquid/"12, and stored at 
-80°C. The samples, each ~20 p,l, were thawed and ground in 200 t~l 
ddH20  in Eppendorf tubes using a  mini-pestle (Kontes Co., Vineland, 
N J). Intact cells were then lysed by four cycles of freezing and thawing 
(5 rain on dry ice, 5 rain at 37°C). The suspension was spun at 3,000 rpm 
(700 g) for 10 s, and 0.5-1 p,1 of lysate, diluted to a final volume of 5 gl in 
ddH20, was used in the GPI assay. 
For analysis of muscle cryosections, muscles were dissected, embedded 
in  mounting medium  (O.C.T.  compound; Miles Laboratories, Elkhart, 
IN), and frozen in isopentane (2-methyl-butane, Aldrich Chemical Co., 
Milwaukee, WI)  cooled in liquid nitrogen. The  muscles were cryosec- 
tioned along their entire lengths. Every 500 p,m, one 30-1~m section was 
collected into a 0.65-ml microcentrifuge tube (cooled to -20°C in the cryo- 
stat) and stored at -80°C. The sections were thawed by the addition of 
5-p.l of ddH20 to each tube, the tissue was subjected to repeated freeze/ 
thaw cycles as above, and the entire sample was used in the GPI assay. 
GPI assay was performed essentially as described by Bradley (1987). 
Briefly, samples were applied (with a Super Z applicator kit, 4088; Helena 
Laboratories, Beaumont, TX) to a cellulose acetate plate (Titan III 3023; 
Helena Laboratories) presoaked in 1 x  TG buffer (25 mM Tris, 200 mM 
glycine, ammonia-free, pH 8.5). Theplate was then subjected to electro- 
phoresis (Zip Zone chamber, 1283; Helena Laboratories) in 1 × TG buffer 
at 150 V and 4°C for 1.5 h. The substrate mixture for staining the isozymes 
contained 2 ml 0.2 M Tris-HCl, pH 8.0, 0.1 m154.1 g/liter magnesium ace- 
tate, 0.1 ml 100 mg/ml fructose-6-phosphate (F3627; Sigma Chemical Co.), 
0.1 ml 10 mg/ml NADP (Na2 salt, N0505, Sigma Chemical Co.), 0.1 ml 10 
mg/ml  methylthiazolium tetrazolium  (MTT)  (M2128;  Sigma  Chemical 
Co.), 0.05 ml 2.5 mg/ml phenazine methosulphate (PMS), (P9625;  Sigma 
Chemical Co.). Right before use, 8 p,l glucose-6-phosphate dehydrogenase 
(G5885;  Sigma Chemical Co.) and melted 1.5% agarose (in water) were 
added to the substrate mixture. The substrate mixture was poured onto 
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ized. The plate was photographed, and the photograph was used for densi- 
tometric analysis. 
Densitometric analysis of the GPI  assays was performed using  1D- 
multi-lane Scan of the IS-1000  Digital Imaging System (Alpha Innotech, 
San Leandro, CA). Percentage of the ES cell--derived  (129/Sv) isoform of 
GPI was calculated as: 
area of the upper band +  1/2 area of the middle band 
total area of the three GPI bands 
X  100%. 
Histological Analysis of Muscle 
For some muscles, both histological and biochemical analyses were per- 
formed on serial cryosections (Rando et al., 1995).  In those muscles, for 
each section collected for GPI  analysis, adjacent 10-1~m serial sections 
were collected onto a gelatin-coated glass slide for histological analysis. 
The sections were stained with hematoxylin and eosin and mounted in 
Pro-Texx  mounting  medium  (American  Scientific  Products,  McGraw 
Park, IL). Microscopic analysis and photography were done using a micro- 
scope (Axiophot; Carl Zeiss, Inc., Thornwood, NY). 
Isolation of Wild-type and a4 
Integrin-deficient Myoblasts 
Muscles from mature wild-type (C57BL/6J) and chimeric mice were disso- 
ciated to isolate pure populations of myoblasts (Rando and Blau, 1994). 
Briefly, the muscles were minced and  enzymatically dissociated with a 
mixture of collagenase (class II, 1%; Boehringer Mannheim Corp., India- 
napolis,  IN)  and  dispase  (grade  II,  2.4  U/ml;  Boehringer  Mannheim 
Corp.). Primary cultures were plated and passaged in growth medium con- 
sisting of F-10 nutrient mixture (GIBCO BRL), 20% FBS (Hyclone Labo- 
ratories, Logan, UT), 2.5 ng/ml basic FGF (Promega Corp., Madison, WI), 
and penicillin (200 U/ml)/streptomycin (200 p,g/ml) (GIBCO BRL). From 
these primary cultures, myoblasts were enriched to ~100% by preplating 
and growth in this selective growth medium (Rando and Blan, 1994). The 
cells were identified as myogenic by staining with an antibody to desmin 
(Kaufman and Foster, 1988). 
From the myoblast cultures of chimeric mouse muscle, cq integrin-defi- 
cient myoblasts were purified by selection in 50 p,g/ml G418 for a week to 
allow the growth only of those cells expressing the neomycin-resistance 
gene from the knockout vector. After G418 selection, an aliquot of the 
cells was analyzed by PCR and Southern blot analysis to confirm the effi- 
cacy of the selection process to eliminate all wild-type cells and to purify 
cq  integrin-deficient cells.  The  myoblast  cultures  were  maintained  in 
G418 indefinitely to maintain selection pressure. 
Analysis of Myoblast Differentiation In Vitro 
For studies of differentiation and fusion, myoblast cultures were placed in 
differentiation medium (DME [GIBCO BRL], 2% horse serum [Hyelone 
Laboratories], and penicillin/streptomycin). In this medium, primary myo- 
blast cultures differentiate and fuse into multinocleated myotubes. The fu- 
sion index, a  measure of the propensity of the cells to fuse, was deter- 
mined microscopically as the ratio of the number of nuclei in myotubes 
(elongated cells with greater than or equal to three nuclei) to the total 
number of nuclei in a  field. 20 random fields at a  magnification of 250 
were analyzed for each cell type. The indices were calculated as the mean 
fusion index at each time, -+ SD. For photography, the differentiated cul- 
ture was fixed for 5 min in 4% paraformaldehyde, stained with 0.01% meth- 
ylene blue in a solution of 50%  ethanol, rinsed with water, stained with 
hematoxylin and Scott's water, and photographed without phase contrast. 
neomycin gene (Yenofsky et al., 1990).  The ES cell lines 
carrying the a4 integrin null mutation are heterozygous. 
To obtain ES cells homozygous for the mutation, one of 
the heterozygous ES cell lines was selected with G418 at a 
concentration (1-1.5  mg/ml) five times higher than that 
used for the  original selection (Yang  et  al.,  1995).  The 
G418-resistant ES colonies were picked and screened by 
Southern blot analysis, and 91% of the drug-resistant colo- 
nies (n =  46) were homozygous for the cx  4 integrin knock- 
out mutation (data not shown). Two independent a4-null 
ES cell lines (4D20  and 4D47)  were expanded and con- 
firmed by Southern blot analysis to be homozygous for the 
a 4 integrin null mutation (Fig. 1). Further Southern blot 
analyses also showed that the vicinity of the mutated ge- 
nomic region was not altered by the selection (data not 
shown). 
These two oq-nuU ES cell lines were used for producing 
chimeric mice by injecting the ES cells into blastocysts de- 
rived  from  wild-type  C57BL/6J  females.  The  chimeric 
mice had both black (from C57BL/6J)  and agouti (from 
129/Sv-derived ES  cells) coat colors. As estimated from 
the agouti coat color, the contribution of cq-null ES cells in 
the chimeric mice ranged from 20-100%. These chimeric 
mice appeared as healthy and active as control mice gener- 
ated by injecting wild-type D3 ES cells or (x4-heterozygous 
ES  cells  (line  182)  into wild-type C57BL/6J blastocysts. 
We have also observed germline transmission of the a4- 
null allele from a male chimera. Thus, many cell types, in- 
cluding mesenchymal cells and sperm, can develop with- 
out (x4 integrins. The skeletal and cardiac muscle tissues 
from mice with 50-100%  ES cell contributions were fur- 
ther analyzed. 
a4-Null ES Cells Were Able to Contribute to Chimeric 
Muscle Tissues 
Contributions of cq-null ES cells in skeletal and cardiac 
muscle tissues were examined using GPI markers (Fig. 2 A). 
Results 
Generation of Chimeric Mice Derived from a~ 
Integrin-deficient (a4-Null) ES Cells 
We have previously generated an oq integrin null mutation 
in a  D3  ES  cell line  (Yang et al.,  1995)  by  replacing  the 
first coding exon of the ct  4 integrin gene with a neomycin- 
resistance  cassette,  which  carries  a  mutant  form  of  the 
Figure 1.  Southern blot analysis of ES cells homozygous for the 
a4 integrin knockout mutation. DNA  extracted from ES cells of 
various lines was digested with PstI. The 3.0-kb fragment was de- 
rived from the wild-type allele; the 3.5-kb fragment was derived 
from the mutated allele. (Lane 1), a4-heterozygote, clone 4D10; 
(lanes 2 and 3) a4-null, clones 4D20 and 4D47, respectively. 
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spectively,  in  129/Sv  and  C57BL/6J  strains,  and  these 
isozymes  can  be  separated  as  distinct  bands  by electro- 
phoresis on a  cellulose acetate plate.  Since GPI isozymes 
are dimers, a hybrid band (GPI-I  ab) is formed as a result of 
heterodimerization between the two isozymes in syncytial 
skeletal muscle tissues (Fig. 2 A, lanes 3-6). To quantitate 
the contribution  of ES cells in the muscle tissues,  the in- 
tensities  of the  GPI bands  were  determined  by densito- 
metric  scanning,  and  the  percentage  of GPI-I  a  isozyme 
(129/Sv)  from  each  muscle  sample  was  calculated.  This 
analysis was performed on skeletal and cardiac muscle tis- 
sues of 29 chimeric mice including 18 et null (13 from line 
4D20 and five from Line 4D47), four et4 heterozygous (line 
182), and seven wild-type (D3) ES cell derived. The results 
are summarized in Table I and show that the a4-null cells 
derived from two independent  ES cell lines  were able to 
Table L Percentage Contributions of ol  4-/- Cells in Chimeric 
Skeletal and Cardiac Muscles 
ES clone 
injected  Coat color*  Skeletal muscle*  Cardiac muscle* 
OL4+/+ ; OL4  -/- 
CM 1  4D47  80  >98  29 
CM6  4D47  90  85  51 
CM 11  4D20  70  89  49 
CM 12  4D20  70  >98  51 
CM 19  4D20  100  >98  64 
CM21  4D20  95  >98  47 
CM25  4D20  100  >98  57 
CM39  4D20  95  87  59 
CM40  4D20  90  88  55 
CM41  4D20  90  97  51 
CM45  4D20  100  >98  50 
CM44  4D20  100  97  ND 
CM73  4D47  100  67  ND 
CM74  4D47  100  >98  ND 
CM75  4D47  70  73  ND 
CM28  4D20  100  >98  ND 
CM51  4D20  100  >98  ND 
CM52  4D20  95  >98  ND 
O~4+J+ ; Ct4  +l- 
Control 1  182  100  76  50 
Control 2  182  95  83  63 
Control 3  182  70  50  42 
Control 4  182  50  52  54 
tX4+/+;  54 +/+ 
Control 5  D3  90  72  51 
Control 6  D3  80  86  45 
Control 7  D3  90  72  21 
Control 8  D3  100  58  10 
Control 9  D3  95  76  57 
Control 10  D3  90  60  51 
Control 11  D3  90  58  ND 
*  Percentage of agouti coat color estimated by eye. 
Percentage contributions  of eq  -/- cells determined by densitometric  scanning  of GP1 
gels as described in the Materials and Methods. 
Figure 2.  GPI assays.  (A)  GPI assays  on  skeletal  and  cardiac 
muscle  tissues  from  ct4-null ES  cell--derived  chimeric  mice. 
(Lanes 1-7) Skeletal muscle;  (lane 8) cardiac muscle. (Lane 1) 
129/Sv wild type; (lane 2) C57BL16J wild type; (lanes 3-8) a4-/-; 
a4 +/+ chimeras (lane 3, CM6; lane 4, CMll; lane 5, CM39; lane 6, 
CM40;  lane  7,  CM45;  lane  8,  CM45).  (Upper band) GPI-Iaa; 
(lower band) GPI-Ibb; (middle band) GPI-I  ab.  Notice  that  the 
GPI-I  ab and GPI-I  bb bands are not detectable in lane 7, indicating 
that this chimeric muscle is >98% 129/Sv a4 -/-. (B) GPI assay of 
sections of skeletal  muscle  from a  single  et4+/+; et4  -/-  chimera 
with a  high percentage contribution of a4 -/- cells.  (Lanes 1--6) 
Muscle sections from one a4÷/+; a4 -/- chimeric muscle.  Notice 
the GPI-P  b and GPI-I  bb bands are not detectable in these lanes. 
(Lane 7) Control chimeric muscle showing the bands of all iso- 
forms.  (Upper band) GPI-Iaa;  (lower band) GPI-Ibb;  (middle 
band) GPI-I  ab. 
contribute to both skeletal  and cardiac muscles. The con- 
tributions of ot4-null  cells to cardiac muscle were similar to 
those of et4-heterozygous and wild-type ES cells,  and the 
contributions  of o~4-null cells  to  skeletal  muscles  appear 
even  a  bit  higher  than  those  observed  with  the  eta-het- 
erozygous and wild-type ES cells. It is noticeable that the 
chimerism in skeletal muscle from the eta-null cell-derived 
chimeras correlated fairly well with that of the coat colors 
of the  mice; skeletal  muscles from mice with  a  high per- 
centage of agouti coat color had a high percentage of con- 
tribution from the et4-null ceils (e.g., Fig. 2 A, lanes 3-7). In 
eight  skeletal  muscle  samples,  GPI-I  bh  and  GPI-I  ah  iso- 
zymes were completely undetectable (e.g., Fig. 2A, lane 7). 
To assess the sensitivity of the GPI assay, we performed a 
serial dilution of a  muscle tissue sample from a wild-type 
mouse  for  GPI  analysis,  starting  with  the  equivalent 
amount  used  for  the  chimeric  muscle  analysis;  the  GPI 
band was still detectable when the sample was diluted 1:50 
(data not shown). Based on this observation, we conclude 
that the muscles in those chimeric mice in which the GPI- 
I bb  and  GPI-I  ab  isozymes  were  undetectable  were  com- 
posed of at least 98% et4-null  cells (e.g., Fig. 2 A, lane 7). 
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Gross Morphological Changes 
Having observed that skeletal muscles of many of the chi- 
meric mice appeared to have been derived predominantly, 
perhaps even exclusively, from the ct4-null ES cells, we an- 
alyzed the muscle histologically for signs of structural ab- 
normalities.  We  chose mice whose coat color suggested 
that the muscle would likely have low or negligible contri- 
bution from wild-type  cells,  and  confirmed this  by GPI 
analysis of the muscle cryosections. Indeed, such an analy- 
sis demonstrated that in one muscle segment of 4 mm in 
length, no contribution from wild-type cells could be de- 
tected (Fig. 2 B). In muscle thus shown to be composed al- 
most entirely of a4-null  cells,  histologic examination re- 
vealed no gross abnormalities (see Fig. 4 A). In particular, 
myofiber alignment  was  not  disrupted,  fiber  diameters 
were uniform and indistinguishable  from wild-type mus- 
cle, no degenerating or regenerating fibers were seen, and 
no central nuclei were observed. Thus, myofiber forma- 
tion is not noticeably disrupted by the absence of ot  4 inte- 
grins. 
~4 Integrin--deficient Myoblasts Fuse As Well As 
Wild-type Myoblasts 
To further assess the role of ~4 integrins in muscle cell dif- 
ferentiation, wild-type and ot  4 integrin-deficient myoblasts 
were compared in  an  in  vitro assay  of myoblast fusion. 
Wild-type myoblasts were derived from primary muscle 
cell cultures from mature C57BL/6J mice. The 0~  4 integrin- 
deficient myoblasts  were  obtained  by  deriving  primary 
myoblast cultures from chimeric mouse muscle, purifying 
the myogenic cells from those cultures, and then selecting 
a4 integrin-deficient cells by growth in G418. The G418- 
resistant population was genotyped by Southern blot anal- 
ysis (data not shown) and by PCR (Fig. 3 A), which should 
detect <1% contribution of wild-type cells, to confirm the 
absence of any wild-type cells in the population. 
Figure 3.  Differentiation of 0t  4 integrin-deficient  myoblasts. (,4) 
PCR analysis of the myoblast cultures. (Lane 1) eq  +/+ (N-cad- 
herin  +/-); (lane 2) a4+/-;  (lane 3) cq  -/-. The PCR products 
were Southern blotted and hybridized with a probe for the ct  4 in- 
tegrin  wild-type bands. The blot was then rehybridized  with a 
probe for the control bands, which are PCR products  from the 
Neo primers.  Notice that the PCR product for the cq integrin 
wild-type allele was absent in lane 3. (B) Histograms of the fusion 
index of ~4  -/- and ct4  +/+ myoblasts at the same time points. No- 
tice that the mutant and wild-type myoblasts fused into myotubes 
in a similar manner. 
The  two  cell populations were differentiated in  vitro, 
and the degree of fusion was assessed microscopically at 
two different times. The a4 integrin-deficient myoblasts 
formed multinucleated myotubes when placed in differen- 
tiation  medium,  and  myotube  formation  increased  be- 
tween day 2 and day 5 (Fig. 3 B  and 4 B). No significant 
difference was  observed between wild-type and ct4 inte- 
grin-deficient myoblasts in their abilities to differentiate 
and to fuse in vitro. 
Differentiation  of a4-Null ES Cells into Myotubes 
We also examined the ability of a4-null ES cells to differ- 
entiate into myotubes. The wild-type and mutant ES cells 
were grown in  suspension  to produce embryoid bodies, 
and  the  embryoid bodies were plated  on gelatin-coated 
coverslips to induce differentiation. Among the multiple 
cell types typical of such  differentiating embryoid body 
cultures, skeletal myotubes were readily detectable. The 
differentiated  cultures  were  stained  with  an  antibody 
against skeletal muscle myosin heavy chain. 34.5% of the 
wells (10 out of 29) with cq-null embryoid bodies and 33% 
of the wells (6 out of 18) with wild-type embryoid bodies 
had multinucleated myotubes. The myotubes formed by 
the Otg-null embryoid bodies (Fig. 5 B) were as well differ- 
entiated as those formed by the wild-type embryoid bodies 
(Fig. 5 A). This result shows that ES cells can differentiate 
into myotubes in the complete absence of ct  4 integrins. 
Discussion 
We have previously generated a null mutation in the gene 
encoding the ~4 integrin subunit and shown that the muta- 
tion was embryonic lethal. To circumvent the problem of 
embryonic lethality and to study the roles of Et  4 integrins in 
later stages  of development, in  this  study we  generated 
chimeric mice by injecting ~t4-null ES cells into wild-type 
blastocysts. We addressed the question of whether et  4 inte- 
grins are essential in skeletal muscle development by ex- 
amining the ability of ot  4 integrin-deficient ES cells to par- 
ticipate in forming skeletal muscles.  Our results showed 
that the et4-null ES cells were able to contribute to skeletal 
muscle  at  high percentages, and  the  skeletal muscle tis- 
sues, where the proportion of a4-null ES cells was >98%, 
appeared morphologically normal. These results show that 
skeletal muscle can differentiate normally in the apparent 
absence of 0t  4 integrins, suggesting that ~4 integrins are not 
essential  for skeletal  muscle  development.  Our  in  vitro 
studies also strongly support the view that et4 integrins do 
not  play  an  essential  role  during  myogenesis.  First,  we 
showed  that  primary myoblasts deficient in  0t  4 integrins 
were able to differentiate to form myotubes; second, we 
showed that et4-null ES cells can also differentiate into myo- 
tubes. These results clearly demonstrate that o~  4 integrins 
are not essential for myogenesis in vitro. 
A study on chimeric mice generated using ES cells lack- 
ing the 131 integrin subunit has previously been reported by 
F~issler  and  Meyer (1995). They showed that  13mull ES 
cell--derived chimeras with high percentage chimerism die 
at early embryonic stages, while those with low percentage 
chimerism (2-25%) can survive to adulthood. In these low 
percentage chimeras, 13~-null cells were able to contribute 
Yang et al. ct  4 Integrins in Skeletal Muscle Development  833 Figure 4.  Morphology of ot4 integrin-deficient  skel- 
etal muscle (A) and ct4  -/- myotubes in culture (B). 
(,4) Histological staining (hematoxylin and eosin) of 
a frozen section from the same series of chimeric 
muscle sections shown in Fig. 2 B, which had no de- 
tectable wild-type contribution.  (B) Micrograph  of 
well-formed myotubes differentiated from or4  -/- myo- 
blasts. 
to most tissues, including skeletal muscle. However, be- 
cause of the low percentage chimerism and the syncytial 
nature of skeletal muscle, these studies do not assess the 
essentiality of fll integrins for skeletal muscle development. 
Our GPI analysis also showed that ct4-null ES cells are 
able to contribute to cardiac muscles at a percentage simi- 
lar to that of wild-type ES cells, suggesting that et  4 inte- 
grins also may not play an essential role in cardiac muscle 
development. This is consistent with our previous study of 
et4-null embryos, showing that 54 integrins play an impor- 
tant role in the formation and maintenance of epicardium 
but do not play any essential roles in cardiac muscle for- 
mation (Yang et al., 1995). Moreover, we have observed 
high percentage contributions of cc4-null ES cells in  the 
generation of agouti coat color, as well as germline trans- 
mission of the a4-null allele from a  male chimera. Thus, 
besides skeletal muscle, cardiac muscle, mesenchymal cells 
(responsible for the agouti coat color) and sperm, can also 
develop without a4 integrins. Given the high efficiency of 
generation of chimeras with a high contribution of a4-null 
cells, many other cell types clearly can develop normally 
without a4 integrins. 
Although our results suggest that ot  4 integrins are not es- 
sential for skeletal muscle development, they do not rule 
out a possible nonessential involvement of ot  4 integrins in 
this process. Immunohistochemical studies by Rosen et al. 
(1992) and Sheppard et al. (1994) have shown that the Ot  4 
integrin subunit and VCAM-1, the counterreceptor of ~t4 
integrins,  are localized on secondary myotubes and  sec- 
ondary myoblasts, respectively, suggesting a role for et  4 in- 
tegrin-VCAM-1  interactions  during  secondary myotube 
fusion. Our results, however, did not reveal an essential 
role of ot  4 integrins in this process. One possible explana- 
tion is that functional overlap may exist among members 
of the integrin superfamily. It has been shown that 0/.7~ 1 is 
expressed  on  secondary myoblasts,  and  there  is  an  in- 
creased expression level of 0t7~ 1 when these secondary myo- 
blasts fuse into secondary myotubes (Song et al., 1992). It 
is possible that both et4f31 and ot7~  1 are involved in second- 
ary myotube fusion. Functional overlap could also explain 
the discrepancy between our in vitro results and the obser- 
vation by Rosen et al. (1992) that an anti-eta integrin anti- 
body inhibited the ability of C2C12 myoblast cells to dif- 
ferentiate into myotubes. A related but distinct possibility 
Figure  5.  Differentiation  of  or4  integrin-defi- 
cient ES cells. The differentiated wild-type (A) 
and cq  -/- (B) cultures were stained with an anti- 
body against skeletal muscle myosin heavy chain. 
Notice that the cq integrin--defieient ES cells dif- 
ferentiate into multinucleated  myotubes as well 
as wild-type ES cells. 
The Journal  of CeU Biology.  Volume 135, 1996  834 is that other adhesion receptors could compensate for the 
10ss of (x  4 integrins by upregulation of expression or func- 
tion. Alternatively, the antibody blocking results could be 
misleading for a variety of reasons. The antibodies could 
be having effects above and beyond merely inhibiting the 
interactions of ~4 integrins and/or VCAM-1.  Apart from 
the relatively trivial possibilities of cross-reaction with, or 
steric hindrance of, other adhesion receptors, it is known 
that some blocking antibodies to integrins can act as ago- 
nists themselves, leading to secondary consequences in ad- 
dition to the blockage of adhesion. Such secondary conse- 
quences can include the transdominant inhibition of other 
integrins in the same cell (Diaz-Gonzalez, F., J. Forsyth, B. 
Steiner,  and  M.H.  Ginsberg,  manuscript  submitted  for 
publication). 
Based on our studies of myogenesis in vitro and in vivo, 
we conclude that skeletal muscle differentiation can pro- 
ceed in the absence of the ot  4 integrins, although we cannot 
rule out the possibility that a small contribution (<2%) of 
ff-4 integrin-expressing cells in vivo that were not detected 
in  our  assays  might  nucleate  skeletal  muscle  formation. 
The temporal expression of the if-4 integrins during devel- 
opment suggested a role for these molecules in the differ- 
entiation process. However, as determined by our assays, 
the processes of cell fusion and differentiation are not de- 
pendent on these integrins. The biological role of the oc  4 in- 
tegrins in myogenesis remains to be determined. 
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